(Q48227112)

9 February 2018

title

Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer (English)

1 reference

9 February 2018

1 reference

1 reference

10

Fountzilas G

1 reference

9 February 2018

author name string

Samantas E

1

1 reference

9 February 2018

Skarlos DV

2

1 reference

9 February 2018

Pectasides D

3

1 reference

9 February 2018

Nicolaides P

4

1 reference

9 February 2018

Kalofonos H

5

1 reference

9 February 2018

Mylonakis N

6

1 reference

9 February 2018

Vardoulakis T

7

1 reference

9 February 2018

Kosmidis P

8

1 reference

9 February 2018

Pavlidis N

9

1 reference

9 February 2018

publication date

1 February 1999

1 reference

9 February 2018

published in

Lung Cancer

1 reference

9 February 2018

volume

23

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

159-168

1 reference

9 February 2018

Chemotherapy of small cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

VP-16 and cisplatin as first-line therapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

The pharmacology of intravenous and oral etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900095-6

7 January 2021

10.1016/S0169-5002(98)00095-6

Identifiers

DOI

1 reference

9 February 2018

release_423qk2euhraavdy4s6mf4cwrb4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/423qk2euhraavdy4s6mf4cwrb4

24 November 2022

mapped directly with Wikidata item

1 reference

9 February 2018